Name: Latest research reports of Divi's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star

7390.0000 60.00 (0.82%)

NSE Jul 22, 2026 11:28 AM

New 52W High in past week

Volume: 196.1K

Divi's Laboratories Ltd.

06 Aug 2025

7390.00

0.82%

Divi's Labs (HOLD): Long-term supply agreements to offset macro headwinds

Hold: Divi's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Earnings below estimates, largely on price erosion pressure in generics offsetting the impact of Kakinada unit 3 on margins

Divi's Laboratories Ltd. is trading above all available SMAs